This is the code and configuration for an OpenSAFELY analysis of antibody and antiviral deployment via NHS COVID-19 Medicine Delivery Units. An accompanying pre-print Trends, regional variation and clinical characteristics of recipients of antivirals and neutralising monoclonal antibodies for non-hospitalised COVID-19: a descriptive cohort study of 23.4 million people in OpenSAFELY is available on MedRxiv.
- The protocol is available on the Open Science Framework.
- Raw analysis outputs, including charts, crosstabs, etc, are published here.
- If you are interested in how we defined our variables, take a look at the study definition; this is written in
python, but non-programmers should be able to understand what is going on there - If you are interested in how we defined our code lists, look in the codelists folder.
- Developers and epidemiologists interested in the framework should review the OpenSAFELY documentation
The OpenSAFELY framework is a Trusted Research Environment (TRE) for electronic health records research in the NHS, with a focus on public accountability and research quality.
Read more at OpenSAFELY.org.
As standard, research projects have a MIT license.